At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 2,000 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
In Brief
An observational study for Benign Prostatic Hyperplasia. Currently recruiting, targeting 2,000 participants across 3 sites.
Signals
Enrolling ahead of pace
Detailed Summary
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesHong Kong
Collaborators--
Timeline
N/ARecruiting
20222023202420252026202720282029203020312032
First PostedMar 2022
Enrollment StartApr 2022
TodayJul 2026
Primary CompletionApr 2032
Study CompletionJul 2032
First PostedMar 23, 2022
Enrollment StartApr 1, 2022
Primary CompletionApr 30, 2032
Study CompletionJul 31, 2032
TodayJul 1, 2026
Enrollment to primary: 10.1 yearsPosted 4.3 years agoPrimary completion in 5.8 years